Lykke Bülow und Mohammad - Info zur Person

(1 - 5 von 5

)

Clinical Impact of FDG-PET/CT Compared with CE ProQuest

search.proquest.com

von M Naghavi-Behzad · · Zitiert von: 3 — Mohammad Naghavi-Behzad 1,2,3,4,* , Hjalte Rasmus Oltmann 1, Tural Asgharzadeh Alamdari 1,. Jakob Lykke Bülow 1, Lasse Ljungstrøm 1, Poul-Erik Braad 1,2. › openview › 1.pdf

Clinical Impact of FDG-PET/CT Compared with CE PubMed

pubmed.ncbi.nlm.nih.gov

von M Naghavi-Behzad · · Zitiert von: 3 — Mohammad Naghavi-Behzad , Hjalte Rasmus Oltmann , Tural Asgharzadeh Alamdari , Jakob Lykke Bülow , Lasse Ljungstrøm , Poul-Erik ... › ...

FDG-PET/CT for Response Monitoring in Metastatic Breast ...

www.mdpi.com

von M Vogsen · · Zitiert von: 7 — ... Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST. by. Marianne Vogsen. 1,2,3,4,5,* ,. Jakob Lykke Bülow. Marianne Vogsen · Jakob Lykke Bülow · Lasse Ljungstrøm · Hjalte Rasmus Oltmann · Tural Asgharzadeh Alamdari · Mohammad Naghavi-Behzad · Poul-Erik Braad · Oke Gerke ... › ... › reprints

Christina Lykke

Person "Bülow" (5)
Vorname "Lykke" (60)
Name "Bülow" (811)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lykke Bülow und Mohammad Person-Info

Clinical Impact of FDG-PET/CT Compared with CE ProQuest

Clinical Impact of FDG-PET/CT Compared with CE PubMed

FDG-PET/CT for Response Monitoring in Metastatic Breast ...

Resultados de búsqueda - "Jakob Lykke"

FDG-PET/CT in Lymphoma: Where Do We Go Now?,Cancers

Alle Infos zum Namen "Lykke Bülow"